Feinberg
Northwestern Medicine | Northwestern University | Faculty Profiles

News Center

  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
  • Press Releases
  • Media Coverage
  • Podcasts
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Menu
  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
  • Press Releases
  • Media Coverage
  • Podcasts
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Home » Genetic Mutations Linked to Severe Epilepsy
Disease Discoveries

Genetic Mutations Linked to Severe Epilepsy

By Nora DunneOct 8, 2014
Share
Facebook Twitter Email
“Our results illustrate the power of clinical exome sequencing to find novel gene mutations in patients with epileptic encephalopathy,” said Jennifer Kearney, PhD, associate professor in Pharmacology.

Northwestern Medicine scientists discovered that genetic mutations in the KCNB1 potassium channel gene can result in severe early onset epilepsy.

They found the mutations in three children with epileptic encephalopathy, a name that refers to a group of epilepsy disorders that cause seizures and difficulties with cognitive and motor development.

“KCNB1 potassium channels are critical for neurons to generate electrical signals and communicate with one another,” said Jennifer Kearney, PhD, associate professor in Pharmacology and a principal author of the study. “They normally dampen excitability of neurons. However, the mutations caused channel dysfunction that in turn causes excessive excitability, resulting in seizures and disrupted development.”

The findings were published in Annals of Neurology.

Many genes have been associated with epilepsy in the past. But various mutations are involved with different types of seizures in different patients.

“It’s difficult to predict which gene might be responsible in a given patient because epileptic encephalopathies are a diverse group of disorders with so many genes involved – many we haven’t discovered yet,” said Kearney.

So the team approached this study without a hypothesis that focused on a specific genetic mutation. Instead, they conducted whole exome sequencing (WES) – sequencing all genes in the human genome that encode proteins – on a child with epilepsy, as well as her unaffected sister and parents, in search of mutations that explain the underlying cause of the disorder. They found a mutation in KCNB1.

Green, teal and red indicate three types of mutations found in the KCNB1 potassium channel.

In a separate study, scientists deleted that very gene in mice and found that risk of seizure increased only slightly. Kearney’s group concluded that full-fledged epileptic encephalopathy is the result of mutations in the gene, not deletion of the gene.

The results applied to two other patients with similar dysfunction whose WES had revealed mutations in KCNB1 earlier without explanation.

“For two of the patients, the identification of KCNB1 mutations as a cause of their disorder came after a long diagnostic odyssey spanning many years,” said Kearney. “Diagnostic uncertainty is very challenging for families, so finally having a cause for the disorder is very valuable for alleviating stress and moving forward with knowledge that may improve medical management.”

Kearney collaborated with Alfred L. George Jr., MD, chair of Pharmacology, on the study.

This research was supported by Scripps Genomic Medicine, NIH-NCATS Clinical and Translational Science Award UL1 RR025774, the Shaffer Family Foundation, the Anne and Henry Zarrow Foundation and National Institutes of Health (NIH) grants U01 HG006476, R01 NS053792, R01 NS032387 and F31 083097.

Genetics Neurology and Neuroscience Patient Care Research
Share. Facebook Twitter Email

Related Posts

Sex-Specific Mechanisms for Major Depressive Disorder Identified in Response to Dysregulated Stress Hormones

Mar 23, 2023

Pre-Surgery Immunotherapy May Increase Survival in Advanced Melanoma

Mar 23, 2023

Hormone Therapy Plus Current Treatments Improves Survival in Prostate Cancer

Mar 22, 2023

Comments are closed.

Latest News

Sex-Specific Mechanisms for Major Depressive Disorder Identified in Response to Dysregulated Stress Hormones

Mar 23, 2023

Pre-Surgery Immunotherapy May Increase Survival in Advanced Melanoma

Mar 23, 2023

Hormone Therapy Plus Current Treatments Improves Survival in Prostate Cancer

Mar 22, 2023

How ChatGPT Has, and Will Continue to, Transform Scientific Research

Mar 21, 2023

New Directions for HIV Treatment

Mar 21, 2023
  • News Center Home
  • Categories
  • Press Release
  • Media Coverage
  • Editor’s Picks
  • News Archives
  • About Us
Flickr Photos
20230317_NM651
20230317_NM610
20230317_NM569
20230317_NM537
20230317_NM331
20230317_NM323
20230317_NM316
20230317_NM336
20230317_NM626
20230317_NM662
20230317_NM655
20230317_NM642

Northwestern University logo

Northwestern University Feinberg School of Medicine

RSS Facebook Twitter LinkedIn Flickr YouTube Instagram
Copyright © 2023 Northwestern University
  • Contact Northwestern University
  • Disclaimer
  • Campus Emergency Information
  • Policy Statements

Type above and press Enter to search. Press Esc to cancel.